AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 21221987 — intervention group
Group type: EXPERIMENTAL
Intervention: Trapezius muscle blood flow (MBF) during HGT
Number of subjects: 45
Study 19961455 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylene blue (MB)
Number of subjects: 172
Study 19961455 — intervention group
Group type: COMPARATOR
Intervention: Rhodamine B (RB)
Number of subjects: 172
Study 17762748 — intervention group
Group type: EXPERIMENTAL
Intervention: fMRI hyperactivation during the first week of recovery
Number of subjects: 0
Study 17762748 — intervention group
Group type: EXPERIMENTAL
Intervention: fMRI results
Number of subjects: 0
Study 15293971 — intervention group
Group type: EXPERIMENTAL
Intervention: Albendazole (400 mg as a single dose)
Number of subjects: 0
Study 15293971 — intervention group
Group type: EXPERIMENTAL
Intervention: Mebendazole (Janssen, 100 mg twice a day for three days)
Number of subjects: 0
Study 15293971 — intervention group
Group type: EXPERIMENTAL
Intervention: Mebendazole (Unibios, 100 mg twice a day for three days)
Number of subjects: 0
Study 15293971 — intervention group
Group type: EXPERIMENTAL
Intervention: Mebendazole (East African Pharmaceuticals, 100 mg twice a day for three days)
Number of subjects: 0
Study 11444712 — intervention group
Group type: EXPERIMENTAL
Intervention: EMLA cream (lidocaine/prilocaine) applied 45 minutes before intravenous cannulation
Number of subjects: 57
Study 11444712 — intervention group
Group type: COMPARATOR
Intervention: Placebo applied 45 minutes before intravenous cannulation
Number of subjects: 57
Study 9655746 — intervention group
Group type: EXPERIMENTAL
Intervention: Histamine challenge
Number of subjects: 20
Study 9655746 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertonic saline (HS) challenge
Number of subjects: 20
Study 9655746 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenosine 5'-monophosphate (AMP) challenge
Number of subjects: 20
Study 9655746 — intervention group
Group type: EXPERIMENTAL
Intervention: Isotonic saline (IS) challenge
Number of subjects: 20
Study 7712340 — intervention group
Group type: EXPERIMENTAL
Intervention: Raw carrots
Number of subjects: 10
Study 7712340 — intervention group
Group type: COMPARATOR
Intervention: Microwaved carrots
Number of subjects: 10
Study 7712340 — intervention group
Group type: EXPERIMENTAL
Intervention: Processed carrots (blanched and frozen)
Number of subjects: 10
Study 2750692 — intervention group
Group type: EXPERIMENTAL
Intervention: Air-expanded whole-wheat protein product (SNW) as a meal substitute for 12 weeks
Number of subjects: 0
Study 2750692 — intervention group
Group type: COMPARATOR
Intervention: Standard low-calorie diet (LCD)
Number of subjects: 0
Study 335516 — intervention group
Group type: EXPERIMENTAL
Intervention: Cranial irradiation plus intrathecal therapy during early remission
Number of subjects: 0
Study 335516 — intervention group
Group type: EXPERIMENTAL
Intervention: Involved field irradiation during induction
Number of subjects: 0
Study 335516 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal methotrexate for prophylaxis of CNS disease
Number of subjects: 0
Study 335516 — intervention group
Group type: EXPERIMENTAL
Intervention: Irradiation to areas of bulk disease
Number of subjects: 0
Study 335516 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternate regimens to the Memorial Hospital LSA2-L2 regimen
Number of subjects: 0
Study 335516 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose methotrexate in combination drug treatment
Number of subjects: 0
Study 335516 — intervention group
Group type: EXPERIMENTAL
Intervention: First or second look laparotomy for surgical bulk reduction
Number of subjects: 0
Study 31398231 — intervention group
Group type: EXPERIMENTAL
Intervention: Care management intervention
Number of subjects: 0
Study 31398231 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 27709313 — intervention group
Group type: EXPERIMENTAL
Intervention: DA-3031 (6 mg on day 2 of each chemotherapy cycle)
Number of subjects: 74
Study 27709313 — intervention group
Group type: COMPARATOR
Intervention: Filgrastim (100 μg/m2/day for up to 10 days)
Number of subjects: 74
Study 27709313 — intervention group
Group type: COMPARATOR
Intervention: Filgrastim
Number of subjects: 74
Study 27709313 — intervention group
Group type: EXPERIMENTAL
Intervention: DA-3031
Number of subjects: 74
Study 25133860 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking workstation
Number of subjects: 10
Study 23616163 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose propranolol (20 mg)
Number of subjects: 11
Study 23616163 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 23616163 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose propranolol (80 mg)
Number of subjects: 11
Study 23616163 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol (100 mg)
Number of subjects: 11
Study 21672315 — intervention group
Group type: EXPERIMENTAL
Intervention: tamsulosin 0.2 mg orally once daily for 4 weeks
Number of subjects: 102
Study 21672315 — intervention group
Group type: COMPARATOR
Intervention: silodosin 4 mg orally twice daily for 4 weeks
Number of subjects: 102
Study 21672315 — intervention group
Group type: EXPERIMENTAL
Intervention: tamsulosin
Number of subjects: 102
Study 21672315 — intervention group
Group type: COMPARATOR
Intervention: silodosin
Number of subjects: 102
Study 19114862 — intervention group
Group type: EXPERIMENTAL
Intervention: tipranavir/ritonavir (TPV/r) 500/200 mg twice daily (b.i.d.)
Number of subjects: 203
Study 19114862 — intervention group
Group type: COMPARATOR
Intervention: Control group (men)
Number of subjects: 203
Study 16917168 — intervention group
Group type: EXPERIMENTAL
Intervention: Tactor trials (balance prosthesis activated)
Number of subjects: 0
Study 16917168 — intervention group
Group type: COMPARATOR
Intervention: Control trials (balance prosthesis not activated)
Number of subjects: 0
Study 12590854 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% boric acid solution in alcohol and frequent suction cleaning of the ear canal
Number of subjects: 87
Study 12590854 — intervention group
Group type: EXPERIMENTAL
Intervention: tioconazole ointment
Number of subjects: 87
Study 12590854 — intervention group
Group type: COMPARATOR
Intervention: Control group (Candida albicans isolate)
Number of subjects: 87
Study 10487457 — intervention group
Group type: EXPERIMENTAL
Intervention: BMV foam 0.12%
Number of subjects: 72
Study 10487457 — intervention group
Group type: COMPARATOR
Intervention: BMV lotion
Number of subjects: 72
Study 10487457 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study 8707075 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological stress (Stroop test)
Number of subjects: 60
Study 8707075 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical stress (cold pressor test)
Number of subjects: 60
Study 8707075 — intervention group
Group type: COMPARATOR
Intervention: Control (no stress)
Number of subjects: 60
Study 1923295 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-fluorouracil
Number of subjects: 32
Study 1923295 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 32
Study 7202249 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimethoprim (TMP), 300 mg once a day for seven days (group 1)
Number of subjects: 322
Study 7202249 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimethoprim (TMP), 200 mg once a day for 10 days (group 2)
Number of subjects: 322
Study 7202249 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrofurantoin, 100 mg four times a day for 10 days (group 3)
Number of subjects: 322
Study 3936374 — intervention group
Group type: EXPERIMENTAL
Intervention: alfentanil
Number of subjects: 51
Study 3936374 — intervention group
Group type: COMPARATOR
Intervention: isoflurane
Number of subjects: 51
Study 30216138 — intervention group
Group type: EXPERIMENTAL
Intervention: Organized recess
Number of subjects: 281
Study 30216138 — intervention group
Group type: COMPARATOR
Intervention: Supervised recess
Number of subjects: 281
Study 26159208 — intervention group
Group type: EXPERIMENTAL
Intervention: 35% HP + LED/laser
Number of subjects: 22
Study 26159208 — intervention group
Group type: COMPARATOR
Intervention: 35% HP
Number of subjects: 22
Study 25440792 — intervention group
Group type: EXPERIMENTAL
Intervention: STENTYS self-apposing nitinol bare-metal stent
Number of subjects: 212
Study 25440792 — intervention group
Group type: COMPARATOR
Intervention: Balloon-expandable bare-metal MULTI-LINK stent
Number of subjects: 212
Study 22789795 — intervention group
Group type: EXPERIMENTAL
Intervention: Spiritual ceremony
Number of subjects: 10
Study 20357041 — intervention group
Group type: EXPERIMENTAL
Intervention: Approximately 4 hours of sleep (from 0200 to 0600)
Number of subjects: 12
Study 20357041 — intervention group
Group type: COMPARATOR
Intervention: Approximately 8 hours of sleep (from midnight to 0800)
Number of subjects: 12
Study 18773686 — intervention group
Group type: EXPERIMENTAL
Intervention: Conservative drug therapy + Su Jok therapy with laser ray at acupuncture points
Number of subjects: 100
Study 18773686 — intervention group
Group type: COMPARATOR
Intervention: Conservative drug therapy only
Number of subjects: 100
Study 16216060 — intervention group
Group type: EXPERIMENTAL
Intervention: Azosemide (30 mg/d for cardiac/renal edema; 60 mg/d for hepatogenic edema)
Number of subjects: 223
Study 16216060 — intervention group
Group type: COMPARATOR
Intervention: Furosemide (20 mg/d for cardiac/renal edema; 40 mg/d for hepatogenic edema)
Number of subjects: 223
Study 14693730 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher concentrations of testosterone (T)
Number of subjects: 600
Study 14693730 — intervention group
Group type: EXPERIMENTAL
Intervention: Free testosterone (free T)
Number of subjects: 600
Study 14693730 — intervention group
Group type: EXPERIMENTAL
Intervention: Percentage of free testosterone
Number of subjects: 600
Study 14693730 — intervention group
Group type: EXPERIMENTAL
Intervention: Total testosterone:sex hormone binding globulin ratio
Number of subjects: 600
Study 14693730 — intervention group
Group type: EXPERIMENTAL
Intervention: Androstenedione
Number of subjects: 600
Study 14693730 — intervention group
Group type: EXPERIMENTAL
Intervention: Dehydroepiandrosterone sulfate
Number of subjects: 600
Study 14693730 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 alpha‐androstanediol glucuronide
Number of subjects: 600
Study 14693730 — intervention group
Group type: EXPERIMENTAL
Intervention: Total estradiol (E2)
Number of subjects: 600
Study 14693730 — intervention group
Group type: EXPERIMENTAL
Intervention: Free estradiol (free E2)
Number of subjects: 600
Study 14693730 — intervention group
Group type: EXPERIMENTAL
Intervention: Percentage of free estradiol
Number of subjects: 600
Study 10507606 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenoldopam 0.03 µg/kg/min
Number of subjects: 14
Study 10507606 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenoldopam 0.1 µg/kg/min
Number of subjects: 14
Study 10507606 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenoldopam 0.3 µg/kg/min
Number of subjects: 14
Study 10507606 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenoldopam
Number of subjects: 14
Study 10507606 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 8619353 — intervention group
Group type: EXPERIMENTAL
Intervention: iobitridol
Number of subjects: 276
Study 8619353 — intervention group
Group type: COMPARATOR
Intervention: iohexol
Number of subjects: 276
Study 1934205 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural morphine
Number of subjects: 30
Study 1934205 — intervention group
Group type: COMPARATOR
Intervention: Patient-controlled intravenous morphine
Number of subjects: 30
Study 7138727 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral diazepam alone
Number of subjects: 8
Study 7138727 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral diazepam with atropine
Number of subjects: 8
Study 7138727 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral diazepam with hyoscine
Number of subjects: 8
Study 7138727 — intervention group
Group type: COMPARATOR
Intervention: Control (diazepam alone)
Number of subjects: 8
Study 31852287 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide mononitrate (IMN) plus 25 µg sublingual misoprostol
Number of subjects: 122
Study 31852287 — intervention group
Group type: COMPARATOR
Intervention: Misoprostol plus placebo
Number of subjects: 122
Study 30798267 — intervention group
Group type: COMPARATOR
Intervention: School-level rigid boundaries
Number of subjects: 0
Study 30798267 — intervention group
Group type: COMPARATOR
Intervention: Student belonging
Number of subjects: 0
Study 30798267 — intervention group
Group type: COMPARATOR
Intervention: Student commitment
Number of subjects: 0
Study 29017658 — intervention group
Group type: EXPERIMENTAL
Intervention: armed stabilization device
Number of subjects: 167
Study 29017658 — intervention group
Group type: COMPARATOR
Intervention: unarmed stabilization device
Number of subjects: 167
Study 27684379 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate treatment for patients with two consecutive viraemia episodes below 3000 genomes/ml
Number of subjects: 59
Study 27684379 — intervention group
Group type: COMPARATOR
Intervention: Monitoring for patients with two consecutive viraemia episodes below 3000 genomes/ml
Number of subjects: 59
Study 27684379 — intervention group
Group type: EXPERIMENTAL
Intervention: Stopping treatment when viraemia is less than 200 genomes/ml
Number of subjects: 59
Study 27684379 — intervention group
Group type: COMPARATOR
Intervention: Stopping treatment when viraemia is less than 3000 genomes/ml
Number of subjects: 59
Study 24402855 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention (6 classes)
Number of subjects: 90
Study 24402855 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 90
Study 22236770 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-adhesive resin cement (RelyX Unicem, RX, 3M ESPE)
Number of subjects: 30
Study 22236770 — intervention group
Group type: COMPARATOR
Intervention: Etch-and-rinse multistep adhesive (Syntac Classic, Ivoclar‐Vivadent) and Variolink II low (SV, Ivoclar‐Vivadent)
Number of subjects: 30
Study 18753005 — intervention group
Group type: EXPERIMENTAL
Intervention: Discontinuation of tricyclic antidepressants (TCAs)
Number of subjects: 57
Study 18753005 — intervention group
Group type: EXPERIMENTAL
Intervention: Discontinuation of selective serotonin reuptake inhibitors (SSRIs)
Number of subjects: 57
Study 18753005 — intervention group
Group type: COMPARATOR
Intervention: Control group (previously untreated patients)
Number of subjects: 57
Study 18753005 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall comparison of TCAs vs SSRIs
Number of subjects: 57
Study 17235721 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic transabdominal (TAPP)
Number of subjects: 66
Study 17235721 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic totally extra peritoneal (TEP)
Number of subjects: 66
Study 17235721 — intervention group
Group type: EXPERIMENTAL
Intervention: Open inguinal hernia repair with polypropylene mesh (Lichtenstein type)
Number of subjects: 66
Study 17235721 — intervention group
Group type: COMPARATOR
Intervention: All groups (TAPP, TEP, Lichtenstein)
Number of subjects: 66
Study 15098798 — intervention group
Group type: EXPERIMENTAL
Intervention: zidovudine plus lamivudine
Number of subjects: 21
Study 15098798 — intervention group
Group type: EXPERIMENTAL
Intervention: ritonavir plus zidovudine and lamivudine
Number of subjects: 21
Study 15098798 — intervention group
Group type: EXPERIMENTAL
Intervention: ritonavir plus stavudine
Number of subjects: 21
Study 15098798 — intervention group
Group type: EXPERIMENTAL
Intervention: ritonavir plus stavudine and nevirapine
Number of subjects: 21
Study 14597359 — intervention group
Group type: EXPERIMENTAL
Intervention: External beam radiation therapy
Number of subjects: 0
Study 14597359 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 10625023 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive intervention group (education, peer‐comparison feedback, academic detailing)
Number of subjects: 1810
Study 10625023 — intervention group
Group type: COMPARATOR
Intervention: Education only group
Number of subjects: 1810
Study 7856779 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-year education program including Quit and Win contests, classes, self-help materials, telephone support, and home correspondence programs.
Number of subjects: 0
Study 7856779 — intervention group
Group type: COMPARATOR
Intervention: Comparison communities (control group)
Number of subjects: 0
Study 1755638 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent treatment for covert bacteriuria for the first four years
Number of subjects: 58
Study 1755638 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 58
Study 6352366 — intervention group
Group type: EXPERIMENTAL
Intervention: pirprofen 400 mg b.i.d.
Number of subjects: 39
Study 6352366 — intervention group
Group type: COMPARATOR
Intervention: indomethacin 50 mg b.i.d.
Number of subjects: 39
Study 29729427 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone (PRED) 7.5 mg once daily (n=12)
Number of subjects: 32
Study 29729427 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone (PRED) 30 mg once daily (n=12)
Number of subjects: 32
Study 29729427 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=8)
Number of subjects: 32
Study 27345175 — intervention group
Group type: EXPERIMENTAL
Intervention: Live attenuated hepatitis A vaccine (HA-L)
Number of subjects: 6000
Study 27345175 — intervention group
Group type: EXPERIMENTAL
Intervention: Inactivated hepatitis A vaccine (HA-I)
Number of subjects: 6000
Study 24160850 — intervention group
Group type: EXPERIMENTAL
Intervention: Arsenic trioxide (ATO)
Number of subjects: 245
Study 22099722 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behaviour Therapy (CBT)
Number of subjects: 76
Study 22099722 — intervention group
Group type: COMPARATOR
Intervention: Supportive Therapy (ST)
Number of subjects: 76
Study 20442102 — intervention group
Group type: EXPERIMENTAL
Intervention: 1064-nm/1320-nm laser-assisted lipolysis (iLAL)
Number of subjects: 3
Study 20442102 — intervention group
Group type: COMPARATOR
Intervention: Tumescence treatment
Number of subjects: 3
Study 20442102 — intervention group
Group type: COMPARATOR
Intervention: Cannulation treatment
Number of subjects: 3
Study 20442102 — intervention group
Group type: COMPARATOR
Intervention: Volume reduction after liposuction
Number of subjects: 3
Study 20442102 — intervention group
Group type: COMPARATOR
Intervention: Deep lasing plus liposuction
Number of subjects: 3
Study 20442102 — intervention group
Group type: EXPERIMENTAL
Intervention: Shallow lasing, liposuction, and deep lasing
Number of subjects: 3
Study 17655677 — intervention group
Group type: EXPERIMENTAL
Intervention: Biventricular (BiV) pacing
Number of subjects: 1636
Study 17655677 — intervention group
Group type: COMPARATOR
Intervention: Right ventricular (RV) pacing
Number of subjects: 1636
Study 16055646 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived opportunity in life domains
Number of subjects: 0
Study 16055646 — intervention group
Group type: EXPERIMENTAL
Intervention: Regret ranking studies
Number of subjects: 0
Study 16055646 — intervention group
Group type: EXPERIMENTAL
Intervention: Laboratory evidence from Study Set 2
Number of subjects: 0
Study 16055646 — intervention group
Group type: EXPERIMENTAL
Intervention: Study Set 3
Number of subjects: 0
Study 12168923 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreotide 600-800 microg/day and chlorpromazine (15-25 mg/day)
Number of subjects: 68
Study 12168923 — intervention group
Group type: COMPARATOR
Intervention: Hyoscine butylbromide 60-80mg/day and chlorpromazine (15-25 mg/day)
Number of subjects: 68
Study 9793253 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrinogen levels
Number of subjects: 2111
Study 9793253 — intervention group
Group type: EXPERIMENTAL
Intervention: White blood cell (WBC) count and serum cholesterol levels
Number of subjects: 2111
Study 9793253 — intervention group
Group type: EXPERIMENTAL
Intervention: Regional distribution of fibrinogen levels
Number of subjects: 2111
Study 8583349 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressurized metered‐dose aerosol inhaler (125 micrograms per dose)
Number of subjects: 17
Study 8583349 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel mechanical pump spray device (500 micrograms per dose)
Number of subjects: 17
Study 2714067 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefotaxime (CTX) (2 Gm Q8H)
Number of subjects: 129
Study 2714067 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefoxitin (2 Gm Q6H)
Number of subjects: 129
Study 2714067 — intervention group
Group type: EXPERIMENTAL
Intervention: Clindamycin (900 mg Q8H) and Gentamicin (3-5 mg/kg/day in divided doses Q8H)
Number of subjects: 129
Study 788731 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin (200 mg daily)
Number of subjects: 6
Study 31021713 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen hormone therapy (HT)
Number of subjects: 100
Study 31021713 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen alone (E-alone)
Number of subjects: 100
Study 31021713 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen with progestin (E + P)
Number of subjects: 100
Study 31021713 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 31021713 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed testing
Number of subjects: 100
Study 28802814 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week regimen of grazoprevir (100 mg/day), ruzasvir (60 mg/day), and uprifosbuvir (450 mg/day) with and without ribavirin
Number of subjects: 676
Study 28802814 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week regimen of grazoprevir, ruzasvir, and uprifosbuvir with and without ribavirin
Number of subjects: 676
Study 28802814 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week regimen of grazoprevir, ruzasvir, and uprifosbuvir with and without ribavirin among participants with cirrhosis infected with genotype 3
Number of subjects: 676
Study 28802814 — intervention group
Group type: EXPERIMENTAL
Intervention: 16-week regimen of grazoprevir, ruzasvir, and uprifosbuvir with and without ribavirin
Number of subjects: 676
Study 28802814 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse events
Number of subjects: 676
Study 26381609 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Habits telephone-based parent intervention
Number of subjects: 394
Study 23679871 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerised experimental training
Number of subjects: 0
Study 23679871 — intervention group
Group type: COMPARATOR
Intervention: Control training
Number of subjects: 0